Sustained-Release Joint Comfort Patch — Documented EV Payload, 8-Hour Wear

The problem this playbook solves: the comfort-patch shelf offers menthol heat or unverified herbal actives — a sustained-release patch with a documented material story is a category vacuum.

01 · The problem

The patch shelf is a wall of menthol, camphor, and herbal heat — actives with sensation but no documentation story, aimed at exactly the buyers (seniors and midlife desk workers) who read labels most carefully. A sustained-release patch carrying characterized exosomal material is a category vacuum: no incumbent owns the documented-transdermal-comfort position, and the format's economics (5-packs, gifting boxes) fit those buyers perfectly.

02 · Scientific rationale

The design principle is sustained release: EV payload distributed in a hydrogel matrix that releases gradually across an 8-hour wear window, measured per batch on retained samples, measured on retained samples batch by batch. Payload-and-release consistency — not sensation marketing — is the credibility mechanism. Placement (knee, shoulder, neck) does the targeting; the format does the discretion — wearable under clothing at work.

03 · Program documentation

Protocol documentation for this program family is maintained in TONGNIAN's internal files — network-clinic protocol series and anonymized case records where applicable [5]. Partner access under NDA; the evidence hierarchy stays explicit — published reviews first, internal observational programs second, case documentation third. [6]

Method anchors: [1] EV biology and cargo [2] MISEV2018 characterization [3] category evidence (review or registered study) [4] formulation and handling guidance [5] national measurement guideline (2026 No. 17) [6] internal protocol and case documentation.

04 · Product architecture

05 · Process & QC

EV material runs on the fully enclosed 0.5–5 L micro-batch line — closed-tubing culture, scheduled harvest, tangential-flow separation and concentration, sterile filtration — with low-shear handling qualified at process validation [4]. QC panel design follows MISEV2018 [2] and the national measurement guideline (2026 No. 17, TONGNIAN a drafting organization) [3].

Fig. 1 — Wear-window design: sustained release across an 8-hour wear.

06 · Regulatory pathway: EU & US first

Comfort-track positioning on both sides of the Atlantic: Wording stays at warming and comfort-routine level; therapeutic joint claims are off the table in both markets. Material chain: DMF Type II 044197 and INCI 41316 on the EV line. China market entry later follows the same cosmetic/comfort framing.

07 · Expected outcomes

• Category whitespace: first-mover shelf story in most markets.
• Gifting economics: 5-packs bundle straight into ready-to-give holiday gift sets.
• Documented batches: payload and release consistency measured per batch.

Wording stays inside each destination market's rules; batch measurement does the persuading.

08 · Commercial framework

Sample kits in 3–5 days; pilot from 500 units; production from 2,000 units; standard lead 15 workdays — all indicative, quoted per request. White-label and program naming run through the OBM program.

Request a quote · Line fact-sheet

References

1. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977.
2. Cobetter. Exosomes Part I: Applications and Downstream Processing Overview. Technical review, 2025.
3. Guideline for Exosome Particle Size and Concentration Measurement (2026 No. 17), national standard — TONGNIAN, drafting organization.
4. TONGNIAN network clinics. Anonymized internal protocol and case documentation (partner access under NDA).